Skip to main content
. Author manuscript; available in PMC: 2023 Aug 28.
Published in final edited form as: Lupus. 2021 Jul 4;30(10):1660–1670. doi: 10.1177/09612033211028658

Table 4.

Top 10 medications concurrently used by cSLE LN patients with and without rituximab treatment

Medication No Rituximab (N=161) Treatment with Rituximab (N=55)
Hydroxychloroquine 155 (96.3%) 53 (96.4%)
Mycophenolate Mofetil 127 (78.9%) 48 (87.3%)
Cyclophosphamide 26 (16.2%) 37 (67.3%)
Aspirin 13 (8.1%) 9 (16.4%)
Mycophenolic Acid 18 (11.8%) 7 (12.7%)
Angiotensin Converting
Enzyme Inhibitor
20 (12.4%) 7 (12.7%)
Azathioprine 18 (11.2%) 7 (12.7%)
Lisinopril 14 (8.7%) 7 (12.7%)
Vitamin D 47 (29.2%) 7 (12.7%)
Immunoglobulin 1 (0.6%) 6 (10.9%)
Tacrolimus 7 (4.4%) 6 (10.9%)